Full Text View
Tabular View
No Study Results Posted
Related Studies
Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors
This study has been completed.
Study NCT00042809   Information provided by National Cancer Institute (NCI)
First Received: August 5, 2002   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
trastuzumab
erlotinib hydrochloride
paclitaxel
Additional drug interventions recognized in this trial
Erlotinib
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Institute for Drug Development
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services